Psychedelic Stock Gainers And Losers From September 21, 2022

迷幻的股票涨跌者，2022年9月21日

Benzinga Real-time News · 2022/09/21 16:36

GAINERS:

赢家：

Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32
Small Pharma (OTC:DMTTF) shares closed up 7.18% at $0.14

复兴治疗学(场外交易：RVVTF)股价收盘上涨7.87%，至0.32美元
小药厂(场外交易代码：DMTTF)股价收盘上涨7.18%，至0.14美元

LOSERS:

失败者：

Mind Medicine (NASDAQ:MNMD) shares closed down 8.71% at $6.39
Cybin (AMEX:CYBN) shares closed down 6.71% at $0.62
ATAI Life Sciences (NASDAQ:ATAI) shares closed down 6.27% at $3.44
Seelos Therapeutics (NASDAQ:SEEL) shares closed down 3.60% at $1.07
Compass Pathways (NASDAQ:CMPS) shares closed down 3.51% at $12.63
Allied (OTC:ALID) shares closed down 3.23% at $0.60
Biomind Labs (OTC:BMNDF) shares closed down 0.99% at $0.99
Numinus Wellness (OTC:NUMIF) shares closed down 0.93% at $0.20
GH Research (NASDAQ:GHRS) shares closed down 0.00% at $11.60

精神医学纳斯达克股价收盘下跌8.71%，至6.39美元
Cybin(美国证券交易所代码：CYBN)股价收盘下跌6.71%，至0.62美元。
阿泰生命科学(纳斯达克：ATAI)股价收盘下跌6.27%，至3.44美元
Seelos治疗公司(纳斯达克代码：SEEL)股价收盘下跌3.60%，至1.07美元
指南针路径(纳斯达克：CMPS)股价收跌3.51%，至12.63美元
盟军(场外交易代码：Alid)股价收盘下跌3.23%，至0.6美元
Biomind实验室(场外交易代码：BMNDF)股价收盘下跌0.99%，至0.99美元
努米诺斯健康(场外交易代码：NUMIF)股价收盘下跌0.93%，至0.20美元
GH研究(纳斯达克代码：GHRS)股价收盘下跌0.00%，至11.60美元

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息